Maine's Drug Crisis and a Vision for the State

On this episode of A Healthy Conversation, co-hosts Dr. Lisa Belisle and Dr. Jeff Barkin are joined in studio by Bobby Charles, a Republican candidate for governor of Maine and a former U.S. Assistant Secretary of State for International Narcotics and Law Enforcement Affairs. Charles traces the path that shaped him, from growing up in a town of 500 in Wayne among World War II veterans, through Dartmouth, Oxford and Columbia Law School, to federal roles in the White House, Navy intelligence and the State Department. He is the author of Eagles and Evergreens, a memoir of a rural Maine childhood, and Cherish America.

Much of the conversation is about health care. Charles argues that Maine's system is in free fall, pointing to hospital closures, rural obstetric and neonatal service reductions, and provider shortages across the state's counties. He frames affordability, quality and access as interlocking problems rather than separate ones, and calls for higher hospital reimbursement, a stronger clinical workforce pipeline and tighter accountability at the state level. Dr. Belisle presses him on where that accountability would actually fall, drawing on her own experience as a chief medical officer, and points to administrative burden rather than clinical work as the reason clinicians leave the profession.

The hosts also take up his central campaign proposal, eliminating Maine's personal and corporate income tax over four years, and ask directly how a rural state with limited fiscal capacity would fund roads, schools and hospitals without it. Charles describes phasing the tax out alongside spending cuts and rolled-back mandates, and argues the money would return to the state economy rather than requiring higher sales or property taxes.

The episode closes on substance use disorder, the subject Charles says brought him into the race. He describes a prevention, treatment and enforcement framework, questions the effectiveness of needle exchange programs, and argues that overdose reversal with naloxone should be the beginning of a treatment pathway rather than the end of one. Dr. Belisle notes that agreement on the substance still leaves the harder question of how a governor sets priorities among competing demands.